MedTrace Logo

Shivering Treatment After Cesarean Delivery: Meperidine vs. Dexmedetomidine

NCT03115047 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-05-27

No results posted yet for this study

Summary

Comparing two treatments for shivering after cesarean delivery for labor dystocia under epidural anesthesia.

Conditions

  • Cesarean Section Complications

Interventions

DRUG

Dexmedetomidine Injection

0.35 mcg/kg intravenous in 2 minutes if shivering 5 minutes after delivery

DRUG

Meperidine Injection

0.35 mg/kg intravenous in 2 minutes if shivering 5 minutes after delivery

Sponsors & Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Anne Lavoie, MD, FRCPC · Centre hospitalier de l'Université de Montréal (CHUM)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-07
Primary Completion
2020-08-19
Completion
2020-08-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03115047 on ClinicalTrials.gov